Appili Therapeutics Inc Class A(APLIF)
$0.01+0.00 (+23.64%)
APLIF
Appili Therapeutics Inc Class A financials statements
$0.01
At close:+0.00 (+23.64%)
Appili Therapeutics Inc Class A (APLIF) Ratios
82 Followers
Appili Therapeutics Inc Class A Ratios
APLIF's free cash flow for Q1 2027 was C$0.00. For the 2027 fiscal year, APLIF's free cash flow was increased by C$36.97K and operating cash flow was C$-36.97K. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.11 | 0.19 | 0.13 | 1.05 | 1.24 |
| Quick Ratio | 0.11 | 0.19 | 0.13 | 1.05 | 1.24 |
| Cash Ratio | 0.00 | 0.08 | 0.01 | 0.83 | 1.00 |
| Solvency Ratio | -0.22 | -0.16 | -0.30 | -0.88 | -2.17 |
| Operating Cash Flow Ratio | -0.07 | 0.06 | -0.21 | -3.39 | -2.86 |
| Short-Term Operating Cash Flow Coverage | -0.11 | 0.08 | -0.34 | -89.26 | -199.69 |
| Net Current Asset Value | C$ -17.34M | C$ -13.42M | C$ -10.95M | C$ -7.41M | C$ -3.31M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 6.56 | 4.05 | 5.49 | 2.45 | 0.60 |
| Debt-to-Equity Ratio | -0.75 | -0.92 | -0.75 | -1.04 | -1.52 |
| Debt-to-Capital Ratio | -2.94 | -11.15 | -2.99 | 28.56 | 2.91 |
| Long-Term Debt-to-Capital Ratio | -0.04 | -0.06 | -0.09 | 48.65 | 3.03 |
| Financial Leverage Ratio | -0.11 | -0.23 | -0.14 | -0.42 | -2.53 |
| Debt Service Coverage Ratio | -0.50 | 0.02 | -0.24 | -6.73 | -14.27 |
| Interest Coverage Ratio | -6.45 | -0.05 | -1.33 | -7.22 | -15.87 |
| Debt to Market Cap | 6.97 | 2.90 | 1.93 | 1.68 | 0.62 |
| Interest Debt Per Share | 0.11 | 0.13 | 0.08 | 0.08 | 0.10 |
| Net Debt to EBITDA | -1.98 | 30.69 | -3.91 | -0.64 | 0.07 |
| Profitability Margins | |||||
| Gross Profit Margin | 96.69% | 100.00% | 100.00% | 98.12% | 100.00% |
| EBIT Margin | -2675.64% | 345.58% | -251.43% | -2427.02% | -1691.61% |
| EBITDA Margin | -2672.33% | 358.98% | -249.78% | -2425.14% | -1690.70% |
| Operating Profit Margin | -2675.64% | -190.00% | -261.39% | -2368.29% | -1774.56% |
| Pretax Profit Margin | -1697.07% | -2594.37% | -448.55% | -2755.01% | -1803.42% |
| Net Profit Margin | -1736.73% | -2613.12% | -456.96% | -2765.90% | -1806.18% |
| Continuous Operations Profit Margin | -1736.73% | -2613.12% | -456.96% | -2765.90% | -1806.18% |
| Net Income Per EBT | 102.34% | 100.72% | 101.87% | 100.40% | 100.15% |
| EBT Per EBIT | 63.43% | 1365.48% | 171.60% | 116.33% | 101.63% |
| Return on Assets (ROA) | -214.89% | -86.55% | -253.68% | -295.08% | -303.30% |
| Return on Equity (ROE) | 24.47% | 19.59% | 34.61% | 124.96% | 768.02% |
| Return on Capital Employed (ROCE) | 39.22% | 1.51% | 21.52% | -5098.06% | -1530.37% |
| Return on Invested Capital (ROIC) | 148.65% | 17.30% | 78.94% | -2949.06% | -1444.76% |
| Return on Tangible Assets | -214.89% | -86.55% | -253.68% | -295.08% | -303.30% |
| Earnings Yield | -228.51% | -61.84% | -89.08% | -203.18% | -313.68% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.14 | 0.06 | 0.71 | 0.79 | 1.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 22.28 | 5.27 | 27.45 | 22.87 | 32.92 |
| Asset Turnover | 0.12 | 0.03 | 0.56 | 0.11 | 0.17 |
| Working Capital Turnover Ratio | -0.02 | -0.01 | -0.17 | 0.39 | 0.18 |
| Cash Conversion Cycle | -273953.28 | -105275.61 | 517.60 | -144040.74 | 365.10 |
| Days of Sales Outstanding | 2693.42 | 6071.79 | 517.60 | 459.60 | 365.10 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 276646.70 | 111347.40 | 0.00 | 144500.33 | 0.00 |
| Operating Cycle | 2693.42 | 6071.79 | 517.60 | 459.60 | 365.10 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | 0.01 | -0.02 | -0.09 | -0.29 |
| Free Cash Flow Per Share | -0.01 | 0.01 | -0.02 | -0.09 | -0.29 |
| Dividend Paid and CapEx Coverage Ratio | -276817.00 | 368.14 | -82.93 | -3180.42 | 0.00 |
| Capital Expenditure Coverage Ratio | -276817.00 | 368.14 | -82.93 | -3180.42 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.11 | 0.07 | -0.30 | -1.32 | -3.83 |
| Operating Cash Flow to Sales Ratio | -5.67 | 8.65 | -2.98 | -30.22 | -13.72 |
| Free Cash Flow Yield | -74.58% | 20.41% | -58.76% | -222.04% | -238.28% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.44 | -1.62 | -1.12 | -0.49 | -0.32 |
| Price-to-Sales (P/S) Ratio | 7.60 | 42.26 | 5.13 | 13.61 | 5.76 |
| Price-to-Book (P/B) Ratio | -0.11 | -0.32 | -0.39 | -0.62 | -2.45 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.34 | 4.90 | -1.70 | -0.45 | -0.42 |
| Price-to-Operating Cash Flow Ratio | -1.34 | 4.89 | -1.72 | -0.45 | -0.42 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.05 | 0.02 | 0.01 | -0.01 |
| Enterprise Value Multiple | -2.26 | 42.46 | -5.97 | -1.20 | -0.27 |
| Enterprise Value | 14.75M | 15.31M | 12.33M | 9.75M | 6.32M |
| EV to EBITDA | -2.26 | 42.46 | -5.97 | -1.20 | -0.27 |
| EV to Sales | 60.41 | 152.43 | 14.91 | 29.17 | 4.55 |
| EV to Free Cash Flow | -10.66 | 17.67 | -4.95 | -0.97 | -0.33 |
| EV to Operating Cash Flow | -10.66 | 17.62 | -5.01 | -0.97 | -0.33 |
| Tangible Book Value Per Share | -0.14 | -0.11 | -0.09 | -0.07 | -0.05 |
| Shareholders’ Equity Per Share | -0.14 | -0.11 | -0.09 | -0.07 | -0.05 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.02 | -0.01 | -0.02 | -0.00 | -0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.01 | 0.00 | 0.02 |
| Net Income Per Share | -0.03 | -0.02 | -0.03 | -0.08 | -0.38 |
| Tax Burden | 1.02 | 1.01 | 1.02 | 1.00 | 1.00 |
| Interest Burden | 0.63 | -7.51 | 1.78 | 1.14 | 1.07 |
| Research & Development to Revenue | 17.58 | 73.00 | 6.80 | 11.40 | 15.43 |
| SG&A to Revenue | 10.15 | 28.41 | 3.68 | 13.28 | 3.32 |
| Stock-Based Compensation to Revenue | 0.00 | 1.17 | 0.23 | 2.62 | 1.47 |
| Income Quality | 0.33 | -0.33 | 0.65 | 1.09 | 0.76 |
Currency in CAD
